US President Trump announced plans to raise pharmaceutical import tariffs from a “small” initial rate to 150 per cent, and eventually 250 per cent, aiming to boost domestic production within 18 months ...

How would you like to have a company in your portfolio that not only has no pressure of interest payments due its zero debt ...

The Trump administration says it's aiming to lower drug costs for Americans. It's given drug companies 60 days to lower ...

President Donald Trump said on Tuesday that the United States would initially place a "small tariff" on pharmaceutical ...

Marta Wosińska, Senior Fellow at the Center on Health Policy at the Brookings Institution, discusses President Trump ...

The U.S. Department of Health and Human Services said on Tuesday it would wind down mRNA vaccine development activities under ...

Holivita from Holiverse uses blockchain-secured data to give users control, enabling personalized preventive healthcare and ...

Pfizer beats Q2 2025 estimates, raises EPS guidance, boasts a 7%+ dividend yield, yet faces patent and pricing risks. See why ...

Pfizer CEO says drugmakers ‘are all ready to roll up their sleeves and execute’ as president demands more direct-to-consumer options ...

U.S. President Donald Trump said that tariffs on imported pharmaceuticals can be as much as 250 percent after initially ...

“We’ll be putting initially a small tariff on pharmaceuticals but in one year—one and a half years maximum—it’s going to go ...

Millions of people are alive today because of leukemia therapies that arose from UC research, including retired Army Major ...